CANNAPHARMARX, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-957.7K | $0 |
| FY2017 | — | $-964.3K | $0 |
| FY2018 | — | $-286.3K | $464.1K |
| FY2019 | — | $4.9M | $1.5K |
| FY2020 | — | $-8.8M | $335.0K |
| FY2021 | — | $-12.9M | $27.8K |
| FY2022 | — | $17.3M | $2.3K |
| FY2023 | — | $-12.2M | $650 |
| FY2024 | — | $-19.8M | $2.2K |
| FY2025 | — | $-30.2M | $1.8K |